Ribavirin Capsule 75 mg (Pregabalin)

Adult dose

This medication is administered orally, twice daily, regardless of meals, with the total daily dosage divided into two doses. 1. Neuropathic Pain - Peripheral neuropathic pain: Starting dose is 150 mg daily, which may be increased to 300 mg daily after 3 to 7 days. If necessary, it may be further increased to a maximum of 600 mg daily at 7-day intervals. - Central neuropathic pain: Starting dose is 150 mg daily, after one week.

Child dose

Safety and efficacy data in children under 12 years old and adolescents aged 12 to 17 are insufficient, so use is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, requiring careful monitoring for symptoms of depression, mood changes, or unusual behavior during treatment. It should not be administered to patients with hypersensitivity to its ingredients or certain genetic lactose metabolism disorders. Diabetic patients may need to adjust the dosage of blood sugar control medications due to weight gain, and should discontinue the medication immediately if symptoms of angioedema occur. Elderly patients require caution due to an increased risk of falls from dizziness and drowsiness, and should consult a healthcare professional if they experience blurred vision or changes in eyesight. Abrupt discontinuation of this medication can lead to withdrawal symptoms such as insomnia, headaches, nausea, and anxiety; therefore, adjustments should be made under a doctor's instructions. Patients with a history of drug abuse require careful administration due to the potential for misuse or dependence on this medication, with close monitoring for signs of drug abuse. Patients with impaired renal function may require dosage adjustments. This medication should be used cautiously in patients with cardiovascular disease, especially those with congestive heart failure. When used in combination with other medications that have central nervous system depressant effects, especially opioids, the risk of respiratory depression is increased. Pregnant women should avoid taking this medication during early pregnancy due to the potential risk of fetal malformations, and women of childbearing age should use effective contraceptive methods. Breastfeeding women should carefully decide on breastfeeding as this medication can be transmitted through breast milk. Dizziness or drowsiness may occur during treatment, so driving or operating dangerous machinery should be avoided until symptoms improve. In case of overdose, severe drowsiness, confusion, or depression may occur, and treatment such as hemodialysis may be required. This medication should be kept out of the reach of children, and transferring it to another container may present a risk of quality degradation or accidents.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin shedding, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attacks, cough accompanied by fever and respiratory issues, jaundice (yellowing of the skin or eyes), severe lethargy, sudden and severe headaches, lightning headache, seizures, confusion of consciousness, visual abnormalities, paralysis, urination.

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 15 degrees Celsius and 30 degrees Celsius to preserve its effectiveness and safety over time.

Appearance

A hard capsule with an upper reddish-brown and a lower white color, containing white powder that is white or light yellow.

Package unit

30 capsules/bottle